At the same time, we found that GZMB secreted by tumor infiltrating CD8+T cells increased, indicating that the function of CD8+T cells were enhanced in the low-dose anti-VEGFR2 group (Fig. 3 h). The gene discussed is GZMB; the disease is neoplasm.